FeesSafety
Pluang+

Fuse Battery Metals secures option to acquire up to 80% of Foggy Mountain copper-gold project in BC

Company Fundamentals
10 Nov 2026, 17:50 WIB
TheNewswire
View Source
Bullish
Fuse Battery Metals secures option to acquire up to 80% of Foggy Mountain copper-gold project in BC

Fuse Battery Metals has entered an option agreement to earn up to an 80% stake in the Foggy Mountain copper-gold-silver project in British Columbia's Toodoggone Mining District. The 4,210-hectare property, near Centerra Gold's Kemess Mine, shows promising historical rock samples with elevated copper, gold, and silver values. Fuse must complete payments, share issuances, and a 3,500-metre drilling program within three years to earn an initial 70% interest, with an option to increase to 80% by completing a preliminary economic assessment. This deal offers Fuse a significant growth opportunity in a well-established mineral region with potential for further exploration and development.

Fuse Battery Metals' Foggy Mountain project is noted here with Pluang's Basic Materials sector context. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 10, 2026 21:31 WIB: out of 83 priced US stocks, only 7 rose while 76 fell. Notable movers include Harmony Gold Mining Co. (HMY) at USD 16.94 with a 3.75% decline and typical hold time of 46 days, Sibanye Stillwater Ltd (SBSW) at USD 9.52 down 3.74%, and Alcoa Corporation (AA) at USD 40.28 down 3.68% with a 6-day typical hold time.

More News

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
1 hour ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
2 hours ago
Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

Global nucleic acid labeling market to hit $2.8B by 2032, driven by genomics and diagnostics growth.

The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...

Market News
Bullish
2 hours ago
MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore launches AI tool to help publishers avoid Google AdSense bans.

MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App